StanleyCA. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Pediatr1987; 34: 59–88.
5.
DuranMWadmanSK. Chemical diagnosis of inherited disorders of fatty acid metabolism and ketogenesis. Enzyme1987; 38: 115–37.
6.
PollittRJ. Disorders of mitochondrial beta-oxidation. Prenatal and early postnatal diagnosis and their relevance to Reye's syndrome and sudden infant death. J Inher Metab Dis1989; 12 (Suppl 1): 215–30.
7.
RoeCRCoatesPM. Acyl-CoA dehydrogenase deficiencies. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis of Inherited Disease. 6th ed.New York: McGraw Hill, 1989; 889–914.
8.
TanakaKCoatesPM, eds. Fatty Acid Oxidation, Clinical, Biochemical and Molecular Aspects. New York: Alan R. Liss, 1990.
9.
StremmelWStrohmeyerGBorchardFKochwaSBerkPD. Isolation and characterization of a fatty acid binding protein in rat liver membranes. Proc Natl Acad Sci (USA)1982; 82: 4–8.
10.
OcknerRKManningJAPoppenhausenRBHoWUL. A binding protein for fatty acids in cytosol of intestinal mucosa, liver myocardium and other tissues. Science1972; 177: 56–58.
11.
BremerJ.Carnitine-metabolism and functions. Physiol Rev1983; 63: 1420–80.
12.
GrootPHEScholteHRHulsmannWC. Fatty acid activation, specificity, localization and function. In: PaolettiRKrichevskyD, eds. Advances in Lipid Research, Vol 10. New York: Academic Press, 1976; 75–126.
HoppelCL. Carnitine palmitoyltransferase deficiency. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 435–50.
15.
IkedaYOkamura-IkedaKTanakaK.Purification and characterization of short-chain, medium-chain and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. J Biol Chem1985; 260: 1311–25.
16.
FongJCSchulzH.Short-chain and long-chain enoyl-CoA hydratases from pig heart muscle. Methods Enzymol1981; 71: 390–8.
17.
El-FakhriMMiddletonB.The existence of two different L-3-hydroxyacyl-coenzyme A dehydrogenases in rat tissues. Biochem Soc Trans1979; 7: 392–3.
18.
MiddletonB.3-ketoacyl-CoA thiolases of mammalian tissues. Methods Enzymol1975; 35: 128–36.
19.
DivryPDavidMGregersenNDicarboxylic aciduria due to medium-chain acyl-CoA dehydrogenase defect. A cause of hypoglycaemia in childhood. Acta Paediatr Scand1983; 72: 943–9.
20.
BennettMJWorthyEPollittRJ. The incidence and presentation of dicarboxylic aciduria. J Inher Metab Dis1987; 10: 241–2.
21.
GregersenNLauritzenRRasmussenK.Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria. Clin Chim Acta1976; 70: 417–25.
22.
GregersenNWintzensenHKolvraaSC6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res1982; 16: 861–68.
23.
DuranMMitchellGdeKlerkJBCOctanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. Pediatrics1985; 107: 397–404.
CoatesPMHaleDEStanleyCACorkeyBECortnerJA. Genetic deficiency of medium-chain acyl-CoA dehydrogenase: Studies in cultured skin fibroblasts and peripheral mononuclear leukocytes. Pediatr Res1985; 19: 671–6.
26.
HaleDEBatshawMLCoatesPMLong-chain acyl-CoA dehydrogenase deficiency. An inherited cause of non-ketotic hypoglycemia. Pediatr Res1985; 19: 665–71.
27.
TaubmanBHaleDEKelleyRI. Familial Reyelike syndrome: A presentation of medium-chain acyl-CoA dehydrogenase deficiency. Pediatrics1987; 79: 382–5.
28.
HowatAJBennettMJShawLVariendS.Deficiency of medium-chain fatty acylcoenzyme A dehydrogenase presenting as sudden infant death syndrome. Br Med J1984; 288: 976.
29.
HowatAJBennettMJVariendSShawLEngelPC. Defect of metabolism of fatty acids in the sudden infant death syndrome. Br Med J1985; 290: 1771–3.
30.
HarpeyJ-PCharpentierCPaterneau-JouasM.Sudden infant death syndrome and inherited disorders of fat metabolism. Lancet1986; ii: 1332.
31.
HarpeyJ-PCharpentierCPaterneau-JouasM.Sudden infant death syndrome and multiple acyl-CoA dehydrogenase deficiency, ethylmalonic-adipicaciduria, or systemic carnitine deficiency. J Pediatr1987; 110: 881–4.
32.
LeaderSudden infant death and inherited disorders of fat oxidation. Lancet1986; ii: 1073–5.
33.
RoeCRMillingtonDSMaltbyDAKinnebrewP.Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reyelike syndromes. J Pediatr1986; 108: 13–8.
34.
DuranMHofkampMRheadWJSaudubrayJ-MWadmanSK. Sudden child death and ‘healthy’ affected members with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics1986; 78: 1052–7.
35.
AllisonFBennettMJVariendSEngelPC. Acylcoenzyme A dehydrogenase deficiency in heart tissue from infants who died unexpectedly with fatty change in the liver. Br Med J1988; 290: 1771–3.
36.
BennettMJAllisonFPollittRJVariendS.Fatty acid oxidation defects as causes of unexpected death in infancy. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 349–64.
37.
StanleyCATreemWRHaleDECoatesPM. A genetic defect in carnitine transport causing primary carnitine deficiency. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 457–64.
38.
TreemWRStanleyCAFinegoldDNHaleDECoatesPM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med1988; 319: 1331–6.
39.
HaleDEStanleyCACoatesPM. The long-chain acyl-CoA dehydrogenase deficiency. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 303–11.
40.
AmendtBAGreeneCSweetmanLCohertyJShihVMoonATeelLRheadWJ. Short-chain acyl-CoA dehydrogenase deficiency: Chemical and biochemical studies in two patients. J Clin Invest1987; 79: 1303–9.
41.
CoatesPMHaleDEFinocchiaroGTanakaKWinterSG. Genetic deficiency of short-chain acyl-CoA dehydrogenase in cultured fibroblasts from a patient with muscle corrective deficiency and severe skeletal muscle weakness. J Clin Invest1988; 81: 171–5.
42.
WandersRJADuranMIjlstLSudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet1989; ii: 52–3.
43.
HaleDEThorpeCBraatKThe L-3-hydroxyacyl-CoA dehydrogenase deficiency. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 503–10.
44.
FrermanFEGoodmanSI. Glutaric aciduria type II and defects of the mitochondrial respiratory chain. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis of Inherited Disease. 6th edition. New York: McGraw Hill, 1989; 915–31.
GregersenNRheadWChristensenE.Riboflavin responsive glutaric aciduria Type II. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 477–94.
BonnefontJ-PTeinISaudubrayJ-PDemaugreF.Hepatic and muscular forms of palmitoyl carnitine transferase deficiency. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 451–6.
49.
BennettMJGrayRGFIsherwoodDMMurphyNPollittRJ. The diagnosis and biochemical investigation of a child with a short-chain fatty acid oxidation defect. J Inher Metab Dis1985; 8: 135–6.
50.
GreenA.When and how should we measure plasma ammonia?Ann Clin Biochem1988; 25: 199–209.
MillsGAWalkerVClenchMRParrVC. Analysis of urinary organic acids by plasmaspray liquid chromatography/mass spectrometry. Biomed Environ Mass Spectrom1988; 17: 259–61.
54.
BhattHRGreenALinnellJC. A sensitive micromethod for the routine estimation of methylmalonic acid in body fluids and tissues using thin layer chromatography. Clin Chim Acta1982; 18: 311–21.
55.
IlesRAHindAJChalmersRA. Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic aciduria. Clin Chem1985; 31: 1795–801.
56.
BennettMJWorthyEPollittRJ. Chromatographic diagnosis of inherited disease of organic acid metabolism. Anal Proc1987; 24: 322–3.
RinaldoPO'SheaJJTanakaK.A stable isotope dilution method for diagnosis of medium-chain acyl-CoA dehydrogenase deficiency. Lancet1987; ii: 1158.
59.
RinaldoPO'SheaJJCoatesPMHaleDEStanleyCATanakaK.Medium-chain acyl-CoA dehydrogenase deficiency: Diagnosis by stable isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N Engl J Med1988; 319: 1308–13.
60.
RinaldoPO'SheaJJWelchRDTanakaK.Stable isotope dilution analysis of n-hexanoylglycine, 3-phenylpropionylglycine, and suberylglycine in human urine using chemical ionization GC/MS selected ion monitoring. Biomed Environ Mass Spectrom1989; 18: 471–7.
61.
RinaldoPO'SheaJJWelchRDTanakaK.Diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by stable isotope dilution analysis of urinary acylglycines: Retrospective and prospective studies and comparison of its accuracy to acylcarnitine identification by FAB/mass spectrometry. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 411–8.
62.
BennettMJCoatesPMHaleDEAnalysis of abnormal urinary metabolites in the newborn period in medium-chain acyl-CoA dehydrogenase deficiency. J Inher Metab Dis (in press).
63.
RoeCRMillingtonDSMaltbyDABohanTPKahlerSGChalmersRA. Diagnostic and therapeutic implications of medium-chain acyl carnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res1985; 19: 459–66.
64.
MillingtonDSNorwoodDLKodoNRoeCRInoueF.Application of fast atom bombardment with random mass spectrometry; and liquid chromatography/mass spectrometry to the analysis of acyl carnitines in human urine, blood and tissue. Anal Biochem1989; 180: 331–9.
65.
RoeCRMillingtonDSKahlerSGKodoNNorwoodDL. Carnitine homeostasis in the organic acidurias. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 383–402.
66.
BhuiyanAKMJWatmoughNJTurnbullDMAynsley-GreenALeonardJVBartlettK.A new simple screening method for the diagnosis of medium-chain acyl-CoA dehydrogenase deficiency. Clin Chim Acta1987; 105: 39–44.
67.
Schmidt-SommerfeldEPennDKernerJBeiberLL. Acyl carnitines in the urine of a patient with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency and in normal children. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 403–9.
68.
PollittRJLostyHWestwoodA.3-hydroxydicarboxylic aciduria: A distinctive type of intermittent dicarboxylic aciduria of possible diagnostic significance. J Inher Metab Dis1987; 10 (Suppl 2): 266–9.
69.
PollittRJ. Clinical and biochemical presentations in 20 cases of hydroxydicarboxylic aciduria. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 495–502.
70.
KarpatiGCarpenterSEngelAGThe syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical and pathophysiologic features. Neurology1975; 25: 16–24.
DuranMMitchellGdeKlerkJBCOctanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr1985; 107: 397–404.
74.
DuranMBruinvisLKettingDdeKlerkJBCWadmanSK. Cis-4-Decenoic acid in plasma: A characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency. Clin Chem1988; 34: 548–51.
75.
SeakinsJWTRumsbyG.The use of phenylpropionic acid as a loading test for medium-chain acyl-CoA dehydrogenase deficiency. J Inher Metab Dis1988; 11 (Suppl 2): 221–4.
76.
DuranMDorlandLBruinvisMLong-chain 3-OH-acyl-CoA dehydrogenase deficiency: in vivo diagnosis using the phenylpropionic acid loading test. Proceedings 27th Symposium Society for the Study of Inborn Errors of Metabolism 1989; PO95 (abstract).
77.
RheadWJ. Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: An overview. In: TanakaKCoatesPM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 1990; 365–82.
78.
LehmanTCHaleDEBhalaAThorpeC.An acyl-CoA dehydrogenase assay using the ferricenium ion. Anal Biochem (in press).